We can't find the internet
Attempting to reconnect
18543.1 PFLS-LS
Allosteric modulators of TrkB, a neuroprotective receptor: advancing compounds towards clinical candidate phase
Résumé
Allosteric modulators of TrkB, a neuroprotective receptor: advancing compounds towards clinical candidate phase
Textes supplémentaires
Abstract
Addex has identified novel small molecules, which are positive allosteric modulators of the neuroprotective receptor TrkB. These compounds, which have a major potential for the treatment of neurodegenerative diseases (e.g. Huntington¿s disease and amyotrophic lateral sclerosis) will be profiled in unique assays developed by the Krause group at University of Geneva. The results obtained will enable the prioritization of compounds for later stages of preclinical development.
Participants
Tim Dyer
Wirtschaftspartner
Tim.Dyer@addexpharma.com
Addex Pharmaceuticals SA Tim Dyer Chemin des Aulx 12 1228 Plan-les-Ouates GE CH
Karl-Heinz Krause
Kontaktperson
karl-heinz.krause@unige.ch
Université de Genève Karl-Heinz Krause Rue Michel Servet 1 1211 Genève GE CH
Détails du projet
- Office de recherche
- INNOSUISSE
- Statut du projet
- Abgeschlossen
- Type de projet
- Forschungsprojekt
- Date de début
- 2016-12-31
- Date de fin
- 2019-03-31
- Coûts totaux approuvés
- CHF 440762.00
- Section
- 20 Förderbereich Life Sciences
- Domaine politique NABS
- Industrielle Produktivität und Technologie
Disciplines de recherche
- T490 Biotechnology 100.0%